The mRNA expression levels of potential mRNA vaccine targets (ITGB2, MYD88, CASP1, BID, PYCARD, and TNFSF10) were examined in our in-house cohorts of LN patients and controls using real-time PCR analysis, further validating the findings (Figure 8). This evidence concerns the gene MYD88 and lobular neoplasia.